Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

2023
type: Class

Generically Dependent Continuant
type: Class

RDF description of Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum - http://research.umh.es/vivo/pub/articulo/263558
type: Document
rights: termsOfUse
date: 2026-08-01T19:16:49
publisher: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
type: Article
type: 2023
has publication venue: FRONTIERS IN MEDICINE
related by: Autor:124345-Artículo:263558
type: Information Content Entity
type: Anualidad
page end: 0
most specific type: 2023
date time value: 263558 pubdate
type: Continuant
type: Document
type: Thing
type: Academic Article
type: Generically Dependent Continuant
page start: 0
ARG_2000028: 263558 vcard
most specific type: Academic Article
type: Entity
included: Medicina Clínica 2023

FRONTIERS IN MEDICINE
type: Information Content Entity
publication venue for: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
type: Entity
type: Generically Dependent Continuant
type: Periodical
type: Thing
type: Journal
type: Continuant
type: Collection

Autor:124345-Artículo:263558
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

Medicina Clínica 2023
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
type: 2023
includes: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum